This is a preview of subscription content, log in via an institution to check access.
Results have also been published in the following papers
Cornel MC, Ten Kate LP, Dukes MNG, De Jong-Van den Berg LTW, Meyboom RHB, Garbis H, et al. Ovulation induction and neural tube defects [letter]. Lancet 1989;1:1386.
De Jong-Van den Berg LTW, Haaijer-Ruskamp FM, Dukes MNG. Registration of drug-use during pregnancy and lactation in computerized community pharmacies. In: Muller NF, Hekster YA, editors. Progress in clinical pharmacy. Noordwijk: AMP, 1990:215–6.
De Jong-Van den Berg LTW, Van den Berg PB, Peters PWJ, Haaijer-Ruskamp FM. A study of drug utilization during pregnancy in the light of known risks: is there room for improvement? Int J Risk Safety Med 1990;1:91–105.
Cornel MC, De Jong-Van den Berg LTW, Koudstaal J, Wiegerinck MAHM, Te Meerman GJ, Ten Kate LP. Aanwijzingen voor een verhoogde kans op defecten van de neurale buis bij zwangerschappen ontstaan na ovulatie inductie en (of) in vitro-fertilisatie [Indications for an increased risk of neural tube defects on outcome of pregnancies after ovulation stimulation and (or)in vitro fertilization]. Ned Tijdschr Geneeskd 1990;134:1357–61.
De Jong-Van den Berg LTW, Van den Berg PB, HaaijerRuskamp FM, Dukes MNG, Wesseling H. Investigating drug use in pregnancy. Methodological problems and perspectives. Pharm Weekbl [Sci] 1991;13(2):32–8.
De Jong-Van den Berg LTW, Waardenburg C. Geneesmiddelengebruik tijdens zwangerschap [Drug use during pregnancy]. Groningen: Styx-publications, 1991.
Collaborative Group on Drug Use in Pregnancy (CGDUP). An international survey on drug utilization during pregnancy. Int J Risk Safety Med 1991;2:345–50.
Collaborative Group on Drug Use in Pregnancy (CGDUP). An international survey on drug utilization during pregnancy. Int J Risk Safety Med 1992;3:49–52.
De Jong-Van den Berg LTW, Van den Berg PB, HaaijerRuskamp FM, Dukes MNG, Wesseling H. Handling of riskbearing drugs during pregnancy, do we choose less risky alternatives? Pharm Weekbl [Sci] 1992;14(2):38–45.
De Jong-Van den Berg LTW, Cornel MC, Van den Berg PB, Bortolussi ACA, Twerda HM, Lappohn R, et al. Ovulationinducing drugs: a drug utilization and risk study in the Dutch population. Int J Risk Safety Med 1992;3:99–112.
Boerdam AA, Hilbink KH, Van den Berg PB, De Jong-Van den Berg LTW. IJzer en zwangerschap. Baat het niet, het schaadt ook niet? [Iron and pregnancy: it can't do any harm and it may do some good]. Pharm Weekbl 1992;127:1010–4.
Ferwerda R, De Jong-Van den Berg LTW, Van den Berg PB, Smilde AK. Drug utilization pattern in pregnancy. J Pharmacoepidemiol 1992;2:35–52.
De Vries CS, De Walle HEK, Cornel MC, De Jong-Van den Berg LTW. Registration of drug use in a birth defect monitoring system: a lot to improve! Int J Risk Safety Med 1993;4:27–33.
Collaborative Group on Drug Use in Pregnancy (CGDUP). Medication during pregnancy: an international cooperative study. Int J Gynecol Obstet 1992;39:185–96.
De Jong-Van den Berg LTW, Waardenburg CM, HaaijerRuskamp FM, Dukes MNG, Wesseling H. Drug use in pregnancy: a comparative appraisal of data collecting methods. Eur J Clin Pharmacol 1993;45:9–14.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
De Jong-Van den Berg, L. Drug utilization studies in pregnancy. Pharm World Sci 15, 171–172 (1993). https://doi.org/10.1007/BF01880561
Issue Date:
DOI: https://doi.org/10.1007/BF01880561